Jaguar Animal Health, Inc. (JAGX) vs Lunai Bioworks Inc. (LNAI)

Jaguar Animal Health, Inc. and Lunai Bioworks Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. is the larger, with a market value of $950.0K against $830.0K — 1.1× the size. Jaguar Animal Health, Inc. has the higher net margin (−188.5% vs −3,761.9%) and the lower return on invested capital (−28,393.6% vs 0.00%). Across the 15 metrics below, Jaguar Animal Health, Inc. leads on 8 and Lunai Bioworks Inc. on 7.

Valuation

Metric JAGX LNAI Biotechnology median
P/E n/m n/m 10.60
P/S 0.00 5.68 9.40
P/B 0.00 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.14 n/m 0.66
EV/Sales (0.12) 0.25 9.02
Earnings yield (1,425,993.60%) (640.81%) (32.88%)
Free cash flow yield (34,129.63%) (988.00%) (23.13%)

Profitability

Metric JAGX LNAI Biotechnology median
Gross margin 82.31% (3.48%) 68.51%
Operating margin (93.10%) (9,184.79%) 0.00%
Net margin (188.46%) (3,761.88%) 0.00%
Free cash flow margin (24.03%) (5,610.24%) 0.00%
Return on equity (1,125.38%) 23.46% (51.96%)
Return on assets (127.14%) (39.21%) (46.06%)
Return on invested capital (28,393.64%) 0.00% 0.00%

Growth

Metric JAGX LNAI Biotechnology median
Revenue growth (TTM) 135.52% — 6.76%
EPS growth (last fiscal year) 82.42% 98.77% 29.88%
Revenue growth, 5-year CAGR 4.17% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAGX LNAI Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 0.69 0.11 4.97
Net debt to EBITDA (0.17) 0.20 1.01

Dividend

Metric JAGX LNAI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JAGX LNAI Biotechnology median
Market cap 950.00k 830.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack